Pharmaceuticals in the Environment - Sources, Fate, Effects and Risks - 3rd Edition
Edited by K Kummerer
The study of pharmaceuticals in the environment as an area of research has only just taken off in recent years.
Since the first edition was printed, many
research articles on this subject have been published. It is exceedingly difficult for the individual,
in particular those not acquainted with the field to establish trends and developments. Even specialists
will appreciate this book, as it provides the reader with a well-founded up dated and enlarged overview
that addresses the latest findings on the new topics in research.
Hardcover XXXII, 522 pp, 91 illus ISBN 9783540746638
Following the resounding success of the first two editions, this new edition has been brought up to
date and greatly extended. It includes the status of research, paying particular attention to sources and
contamination of the environment, substance flows, effects, risk assessment and risk management.
In line with the newest developments worldwide there are again contributions from well known and
new international authors. This volume also caters for the new requirements confronting European and
American researchers since publication of the second edition.
Written for: Libraries, institutes, researchers, scientists in the fields of environmental sciences including
environmental medicine, microbiology, analytical chemistry.
- General Aspects.
- Sources, Occurrence and Fate.
- Risk Assessment.
- Risk Management.
Contents of 2nd Edition
Part I Introduction
1 Pharmaceuticals in the Environment -Scope of the Book and Introduction
2 Special Characteristics of Pharmaceuticals Related to Environmental Fate
Part II Use and Occurence of Pharmaceuticals in the Environment
3 Emissions from Medical Care Units
4 Pharmaceuticals in the Environment: Changes in the Presenceand Concentrations of Pharmaceuticals for Human Use in Italy
5 Environmental Exposure of Antibiotics in Wastewaters, Sewage Sludges and Surface Waters in Switzerland
6 Pharmaceuticals in the Canadian Environment
7 Occurrence of Human Pharmaceuticals in Water Resources of the United States: A Review
8 Strategies for Selecting Pharmaceuticals to Assess Attenuation During Indirect Potable Water Reuse
9 Residues of Clofibric Acid, Ibuprofen and Diclofenac in the Aquatic Environment and their Elimination in Sewage Treatment and Drinking Water Production
10 Drugs in Municipal Landfills and Landfill Leachates
11 Antibiotics in Soil: Routes of Entry, Environmental Concentrations, Fate and Possible Effects
12 Use of Veterinary Pharmaceuticals in the United States
13 Use and Environmental Occurrence ofVeterinary Pharmaceuticals in United States Agriculture
14 Fate of Veterinary Medicines Applied to Soils
Part III Fate and Effects of Pharmaceuticals in the Environment
15 Pharmaceuticals as Environmental Contaminants: Modelling Distribution and Fate
16 Effects of Pharmaceuticals on Aquatic Invertebrates The Example of Carbamazepine and Clofibric Acid
17 What Do We Know about Antibiotics in the Environment?
18 Resistance in the Environment
19 Effects of Ethinyloestradiol and Methyltestosterone inProsobranch Snails
Part IV Risk Assessment and Risk Management
20 Risk Assessment of Organic Xenobiotics in the Environment
21 Environmental Risk Assessment of Medicinal Products for Human Use: Aspects of Its Regulations in the European Union, Canada and United States
22 Environmental Risk Assessment of Pharmaceuticals in the EU - A Regulatory Perspective
23 The ECO-SHADOW Concept - A New Way of Following Environmental Impacts of Antimicrobials
24 A Data-based Perspective on the Environmental Risk Assessment of Human Pharmaceuticals I - Collation of Available Ecotoxicity Data
25 A Data Based Perspective on the Environmental Risk Assessment of Human Pharmaceuticals II - Aquatic Risk Characterisation
26 A Data Based Perspective on the Environmental Risk Assessment of Human Pharmaceuticals III - Indirect Human Exposure
27 Plasma Concentrations of Human Pharmaceuticals as Predictors of Pharmacological Responses in Fish
28 Using (Quantitative) Structure-Activity Relationships in Pharmaceutical Risk Assessment
29 Removal of Pharmaceutical Residues from Contaminated Raw Water Sources by Membrane Filtration
30 Potential Environmental Risks by Cleaning Hair and Skin - Eco-Label - A Possibility to Reduce Exposure to Personal Care Products
Part V Need for Further Research
31 Risks Related to the Discharge of Pharmaceuticals in the Environment: Further Research Is Needed
32 Methodological Aspects Concerning the Environmental Risk Assessment for Medicinal Products - Research Challenges
33 PPCPs in the Environment: Future Research - Beginning with the End Always in Mind
Part VI Conclusion
To find similar publications, click on a keyword below:
: environmental impact
: environmental science
: health & beauty
: modelling, computer & mathematical
: risk assessment
: waste treatment
: water science